Home > Latest News on ID > Interesting Papers

ALLStaphylococcus aureusStreptococcus pneumoniaeEnterococcusEnterobacteriaceaePseudomonas,AcinetobacterOther bacterial infectionOther bacterial infectionClinical issues on bacterial infectionsVaccines No. Category Subject Date Read 84 Streptococcus pneumoniae Hyper-recombination, diversity, and antibiotic resistance in pneumococcus Science. 2009;324(5933):1454-7 2009-07-27 156165 83 Streptococcus pneumoniae Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome Clin Infect Dis. 2009;49(2):e23-9 2009-07-27 156705 82 Clinical issues on bacterial infections Antimicrobial use: risk driver of multidrug resistant microorganisms in healthcare settings Curr Opin Infect Dis. 2009;22(4):352-8 2009-07-13 153574 81 Clinical issues on bacterial infections Isolation precautions for antibiotic-resistant bacteria in healthcare settings Curr Opin Infect Dis. 2009;22(4):339-44 2009-07-13 154094 80 Staphylococcus aureus Comparative evaluation of epidemiology and outcomes of MRSA USA300 infections causing community- and healthcare-associated infections. IJAA 2009;34(2):148-55 2009-07-13 154792 79 Staphylococcus aureus Nasal decolonization of S. aureus with mupirocin: strengths, weaknesses and future prospects J Antimicrob Chemother. 2009;64(1):9-15 2009-07-13 154043 78 Staphylococcus aureus Topical therapy for MRSA colonization: impact on infection risk Infect Control Hosp Epidemiol. 2009;30(7):623-32 2009-06-22 157037 77 Staphylococcus aureus Serious infections due to MRSA: an evolving challenge for physicians. Eur J Intern Med. 2009;20(4):343-7 2009-06-22 155415 76 Staphylococcus aureus The cost of resistance: incremental cost of MRSA in German hospitals. Eur J Health Econ. 2009;10(3):287-97 2009-06-22 156970 75 Staphylococcus aureus Comparison of CA-MRSA from teaching hospitals in London and the USA, 2004-2006: where is USA300 in the UK? Eur J Clin Microbiol Infect Dis. 2009;28(7):835-9 2009-06-22 156520 74 Vaccines Challenges in the evaluation and licensing of new pneumococcal vaccines, 7-8 July 2008, Ottawa, Canada Vaccine. 2009 Jun 8;27(28):3681-3688 2009-06-09 155045 73 Vaccines Global serotype distribution among S. pneumoniae isolates causing otitis media in children: Potential implications for pneumococcal conjugate vaccines 2009-06-09 156013 72 Streptococcus pneumoniae Epidemiological evidence for serotype-independent acquired immunity to pneumococcal carriage J Infect Dis. 2009 Jul 1;200(1):99-106 2009-06-09 157516 71 Clinical issues on bacterial infections Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies. Int J Antimicrob Agents. 2009 Jul;34(1):8.e1-9 2009-06-09 155957 70 Streptococcus pneumoniae Association between fluoroquinolone usage and a dramatic rise in ciprofloxacin-resistant S. pneumoniae in Canada, 1997-2006. 2009-06-09 154747 Page: 1 . 2 . 3 . 4 . 5 . 6 . 7 . 8 . 9 . 10 . ... 11

Writer Subject Content